Ann: new issue, page-71

on its ‘research achieving market recognition’

seriously, and no offence to any holders who have hope here, I have kicked the tires of this a little now:

1) capital structure and funding is woeful

2) there is ZERO IP in terms of COVID killing sanitisation, they have simply paid a premium to HCT for their IP in Pathaway, all SKN have is like some aloe Vera skin cream

3) there production facilities at 20k bottles won’t even cover costs

I don’t intent to hang around debating nickel and dime rubbish with trolls and die hard. But for your your average mum and dad investor this is a ver sorry stare of affairs

this is at its best an embarrassing attempted ride in the coatails on COVID wave 2, and at its worst a total sham